or Try an Advanced Search...

    Technical Analysis for AZTR - Azitra Inc.

    Grade Last Price % Change Price Change
    D 0.26 0.00% 0.00
    AZTR closed unchanged on Wednesday, May 8, 2024, on 5.72 times normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical AZTR trend table...
    Date Alert Name Type % Chg
    Volume Surge Other 0.00%
    Calm After Storm Range Contraction 0.00%
    Doji - Bearish? Reversal 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Outside Day Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Jack-in-the-Box Bullish Bullish Swing Setup 0.00%
    Calm After Storm Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Older End-of-Day Signals for AZTR ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 11 hours ago
    Reversed from Up about 11 hours ago
    Outside Day about 11 hours ago
    Down 5% about 11 hours ago
    Down 3% about 11 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    AZTR Chart by TradingView
    Basic chart:

    Profile

    Azitra Inc, a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Life Sciences Rare Diseases Molecular Biology Epidermal Growth Factor Receptor Genodermatoses Skin Diseases Netherton Syndrome Pre Clinical Biopharmaceutical Biotherapeutic Products Ichthyosis

    Is AZTR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 5 Wall Street Breakfast: The Week Ahead
    Apr 22 Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting
    Apr 18 Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024
    Apr 2 Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying
    Mar 15 Azitra GAAP EPS of -$1.83, revenue of $0.69M
    Mar 15 Azitra, Inc. Announces Full Year 2023 Financial Results and Provides Business Updates
    Feb 16 Azitra, Inc. Announces Closing of Public Offering
    Feb 14 Dow Edges Higher; QuidelOrtho Shares Plummet
    Feb 14 Nasdaq Gains 100 Points; Kraft Heinz Sales Miss Views
    Feb 14 Why Robinhood Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
    See more AZTR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.18
    52 Week Low 0.1605
    Average Volume 679,992
    200-Day Moving Average 1.27
    50-Day Moving Average 0.22
    20-Day Moving Average 0.22
    10-Day Moving Average 0.23
    Average True Range 0.03
    RSI (14) 58.33
    ADX 21.41
    +DI 26.39
    -DI 13.97
    Chandelier Exit (Long, 3 ATRs) 0.20
    Chandelier Exit (Short, 3 ATRs) 0.25
    Upper Bollinger Bands 0.27
    Lower Bollinger Band 0.17
    Percent B (%b) 0.94
    BandWidth 45.32
    MACD Line 0.00
    MACD Signal Line -0.01
    MACD Histogram 0.0112
    Fundamentals Value
    Market Cap 3.15 Million
    Num Shares 12.1 Million
    EPS -1.23
    Price-to-Earnings (P/E) Ratio -0.21
    Price-to-Sales 22.01
    Price-to-Book 2.59
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.35
    Resistance 3 (R3) 0.35 0.32 0.33
    Resistance 2 (R2) 0.32 0.30 0.32 0.33
    Resistance 1 (R1) 0.29 0.28 0.29 0.29 0.32
    Pivot Point 0.26 0.26 0.26 0.26 0.26
    Support 1 (S1) 0.23 0.24 0.23 0.23 0.20
    Support 2 (S2) 0.20 0.23 0.20 0.19
    Support 3 (S3) 0.17 0.20 0.19
    Support 4 (S4) 0.17